Eligibility Module

Eligibility Module

The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.

Eligibility Module path is as follows:

Study -> Protocol Section -> Eligibility Module

Eligibility Module


Ignite Creation Date: 2025-12-24 @ 11:14 PM
Ignite Modification Date: 2025-12-24 @ 11:14 PM
NCT ID: NCT02453269
Eligibility Criteria: Inclusion Criteria: * To be eligible for the study, children should * be overweight or obese in accordance with the definition given above6, * be considered healthy by a physician after undergoing a clinical examination, * attend the transdisciplinary intervention sessions once a week (minimum attendance required: 90%) * be authorized to participate by their parents or caretakers. * The children in the control group were not submitted to the intervention and were not participating in any other program involving obesity control or supervised physical activity. * All children (G1+G2) were instructed to maintain their habitual level of physical activity and attend the school's regular physical education classes. * The latter were scheduled twice a month during the first term and four times a month during the second. * The decision to increase the frequency was made by the school's director in acknowledgment of the importance of physical activity, but the change affected the two groups equally. Exclusion Criteria: * Children were ineligible if they had chronic diseases (defined as diseases requiring continuous therapy), mental disorders or cognitive impairments which might interfere with communication, or used a pacemaker, or declined participation. * Children in G1 missing more than 10% of the total intervention sessions were excluded from the sample.
Healthy Volunteers: True
Sex: ALL
Minimum Age: 7 Years
Maximum Age: 11 Years
Study: NCT02453269
Study Brief:
Protocol Section: NCT02453269